GETINGE Aktie

 

To support the cosmetic and petrochemical industries in key markets, Getinge is extending its range of Lancer Ultima Freestanding Washers with the new heavy-duty model Ultima 1600 LXP/HE-HD. [image] The Ultima1600LXP/HE heavy-duty model is designed to clean components used in the cosmetics industry, as well as different glassware used in petrochemical laboratories.   “Input from our local organizations indicates that there is an increased demand for heavy-duty washers in key markets, such as the United States and France, and the Ultima1600LXP/HE-HD has the capability and high-quality...

Getinge announces the extension of its Servo-c ventilator with a neonatal option, transforming it into a universal solution that supports respiratory care for all patient categories – from fragile premature newborns to fully grown adults. [image] Since its launch, the Servo-c ventilator has earned praise for its modern appearance, intuitive design and great versatility. Now, Getinge is taking the offering to the next level. “Hospitals are under increasing pressure to deliver high-quality care for diverse patient needs while managing costs. Servo-c now supports this by enabling...

Using Getinge's Fluoptics Near Infrared (NIR) imaging technology has helped Halle University Hospital in Germany reduce unintentional removal of parathyroid tissue, which can cause serious consequences for patients undergoing endocrine surgery. [image] The Fluoptics technology enables the combined use of autofluorescence and fluorescence imaging with indocyanine green (ICG) in real time. This allows surgeons to accurately visualize both the location and perfusion of the parathyroid glands, and provides intraoperative guidance to significantly increase parathyroid gland identification...

Getinge has successfully installed solar panels on the roof of its production facility in the Halland town of Getinge. Combined with electricity from a nearby solar park, this means that 99.9% of the energy used at the production facility now comes from renewable sources. [image] The solar installation covers approximately 3,000 square meters of panels and was commissioned in May 2024. Together with electricity from the nearby solar park in Susedalen, about 55% of the annual electricity needs at Getinge's production facility in Halland are now met by locally produced renewable energy. The...

Mölndal, Sweden, June 16[th], 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that Louise Wåhlin has been appointed new Chief Financial Officer. She will take on her new position on September 15[th] 2025. Louise Wåhlin has broad experience from senior finance roles at companies such as Getinge and Polestar and, most recently, as CFO for Capture Energy. Her education includes studies at the Gothenburg School of Economics. Louise is succeeding Jörgen Svanström, interim CFO, who will be available during the transition. "I welcome Louise Wåhlin to...

Das Instrument GTN SE0000202624 GETINGE AB B FR. SK-,50 EQUITY wird ex Dividende/Zinsen gehandelt am 23.04.2025 The instrument GTN SE0000202624 GETINGE AB B FR. SK-,50 EQUITY has its ex-dividend/interest day on 23.04.2025...

Getinge AB (publ)'s Annual General Meeting (“AGM”) was held on April 22, 2025 in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. At the AGM, the following was resolved. Adoption of the Income Statement and the Balance Sheet The AGM adopted the Income Statement and the Balance Sheet as well as the Consolidated Income Statement and the Consolidated Balance Sheet for the financial year 2024. Dividend In accordance with the proposal by the Board of Directors and the CEO, the AGM resolved to declare a dividend of SEK 4.60 per share. Thursday April 24, 2025 was determined as record date...

GOTHENBURG, Sweden, April 22, 2025 /PRNewswire/ -- "We are entering 2025 with healthy organic sales growth and improved adjusted operating profit despite headwinds from currency effects," says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased......

“We are entering 2025 with healthy organic sales growth and improved adjusted operating profit despite headwinds from currency effects,” says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased organically by 6.2% while the order intake rose by 2.9% organically. The performance in the quarter was mainly driven by Acute Care Therapies, where Getinge as a leading supplier is working intensively to meet higher customer demand for ventilators and consumables in ECLS. “We also see that the positive trend for Sterile Transfer in Life Science is continuing,...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Das Instrument GTN SE0000202624 GETINGE AB B FR. SK-,50 EQUITY wird cum Dividende/Zinsen gehandelt am 22.04.2025 und ex Dividende/Zinsen am 23.04.2025 The instrument GTN SE0000202624 GETINGE AB B FR. SK-,50 EQUITY has its pre-dividend/interest day on 22.04.2025 and its ex-dividend/interest day on 23.04.2025...

As the Nordic region's largest healthcare market and a leading life science nation, Sweden is an attractive environment for healthtech companies that want to scale. And Gothenburg offers a compelling entry point. The region features one of Europe's largest university hospitals and excels in life science. It has an exciting mix of large global companies like AstraZeneca, Getinge, Mölnlycke Health Care, Cochlear and Essity, and a strong startup scene. The spirit of collaboration and sustainability credentials make it a hotspot for health innovation. On 7-9 April, around 30 innovative...

Getinge will issue its Q1 Report 2025 on April 22, 2025, at 12.00 p.m. CEST, followed by a conference call at 13:00 p.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO. Fund managers, analysts and media are invited to participate in the conference call. To participate via teleconference, please register via this link (https://conference.inderes.com/teleconference/?id=5009498). After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference. During the...

GOTHENBURG, Sweden, March 27, 2025 /PRNewswire/ -- Today, Getinge publishes its Annual Report, including Sustainability Report, for 2024. The report summarizes a year characterized by strong growth, increased customer satisfaction, and successful product launches. The global medtech......

Today, Getinge publishes its Annual Report, including Sustainability Report, for 2024. The report summarizes a year characterized by strong growth, increased customer satisfaction, and successful product launches. The global medtech company has reached new sales records, strengthened its acquisitions, and continued to develop innovative solutions that improve healthcare – all while maintaining a strong focus on quality improvements and adapting to increasing market demands. “2024 was a record year for Getinge. We have grown significantly, maintained high customer loyalty, and launched highly...

Meet Alisa Stafford, an Office Administrator at Getinge who recently took on a new challenge by stepping in front of the camera to represent the company's purpose to make life-saving technology accessible to more people. [image] When asked what inspired her to participate in Getinge's company video, Alisa shared: “I was intrigued by the idea of using employees to showcase how deeply our purpose impacts people. It's not just about the products we create – it's about the lives we touch.” The theme of darkness versus light resonated deeply with her.  “When patients face life-...

Getinge announces the launch of its latest innovation in ICU ventilation – Neural Pressure Support (NPS) – available for both invasive and non-invasive ventilation. Building on its most personalized ventilation modes, NAVA and NIV NAVA, these two new NPS modes offer clinicians more options to provide personalized ventilation that aims to protect both the lungs and diaphragm. [image] For years, Getinge has been market-driving when it comes to developing first-of-its-kind intensive care ventilation modes. Today, the medtech company is introducing NPS and NIV NPS to widen its groundbreaking...

The shareholders of Getinge AB (publ), corporate ID No. 556408-5032, (“Getinge”) are hereby invited to attend the Annual General Meeting (the “AGM”) on Tuesday, April 22, 2025 at 3.00 p.m. CEST, in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. Entrance registration starts at 2.00 p.m. CEST. A lighter snack will be served after the AGM. The Board of Directors of Getinge has decided that the shareholders shall be able to exercise their voting right the AGM by postal voting in accordance with the regulations in Getinge's Articles of Association, as further described below. RIGHT TO ATTEND...

The Nomination Committee of Getinge AB (publ) proposes that Ulrika Dellby is elected as new Board member at the Annual General Meeting (“AGM”) on April 22, 2025. Further, the Nomination Committee proposes re-election of all current Board members. [image] Ahead of the AGM on April 22, 2025, the Nomination Committee proposes re-election of all current Board members and new election of Ulrika Dellby. Ulrika Dellby has solid experience of strategy, acquisitions and business development as management consultant. She also has long and extensive experience from Board work. The Nomination...

Getinge is introducing its new DPTE[®]-FLEX, a manual, externally openable port. This new port enhances safety, efficiency, and compliance in pharmaceutical manufacturing by allowing secure, gloveless transfers, which reduces human intervention and contamination risks. This complements their existing products, the DPTE[®]-XS and DPTE[®]- EXO Alpha ports. [image] “The external handles of the DPTE[®]-FLEX perform dual functions - unlocking/locking and opening/closing - all accessible from outside the enclosure, says Anneke Evers, Director Aseptic Transfer Portfolio at Getinge. ”When...